Literature DB >> 7657594

Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding.

S A Cunningham1, M N Waxham, P M Arrate, T A Brock.   

Abstract

We have examined the interactions of the p85 regulatory subunit of phosphatidylinositol 3-kinase with the endothelium-specific Flt-1 receptor tyrosine kinase using the yeast two-hybrid system. We find that both the amino- and carboxyl-terminal SH2 domains of p85 bind to Flt-1. We have performed site-directed mutagenesis on the carboxyl-terminal tail of the Flt-1 receptor in order to identify the site(s) that is responsible for the p85 interactions. A single tyrosine to phenylalanine change at position 1213 inhibits the binding of both p85 SH2 domains. Phosphopeptide mapping of the wild type and mutant protein expressed in insect cells verifies that this amino acid is a target for autophosphorylation. The amino acids following this tyrosine are VNA and thus define a novel binding site for p85.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657594     DOI: 10.1074/jbc.270.35.20254

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration.

Authors:  Changsheng Lin; Jason Ear; Yelena Pavlova; Yash Mittal; Irina Kufareva; Majid Ghassemian; Ruben Abagyan; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

Review 2.  Biological properties of VEGF/VPF receptors.

Authors:  B I Terman; M Dougher-Vermazen
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.

Authors:  A L Breeze; B V Kara; D G Barratt; M Anderson; J C Smith; R W Luke; J R Best; S A Cartlidge
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

4.  The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.

Authors:  A J Warner; J Lopez-Dee; E L Knight; J R Feramisco; S A Prigent
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Authors:  B Bussolati; C Dunk; M Grohman; C D Kontos; J Mason; A Ahmed
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

6.  A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.

Authors:  H Gille; J Kowalski; L Yu; H Chen; M T Pisabarro; T Davis-Smyth; N Ferrara
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

7.  Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.

Authors:  Y Yu; J D Hulmes; M T Herley; R G Whitney; J W Crabb; J D Sato
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

8.  RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway.

Authors:  Feng Wang; Mai Yamauchi; Masashi Muramatsu; Tsuyoshi Osawa; Rika Tsuchida; Masabumi Shibuya
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

9.  VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium.

Authors:  Mahesh Thirunavukkarasu; Bela Juhasz; Lijun Zhan; Venugopal P Menon; Arpad Tosaki; Hajime Otani; Nilanjana Maulik
Journal:  Free Radic Biol Med       Date:  2007-02-20       Impact factor: 7.376

10.  Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt.

Authors:  C D Kontos; T P Stauffer; W P Yang; J D York; L Huang; M A Blanar; T Meyer; K G Peters
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.